90% of oesophageal dysplastic lesions, as well as cancers, exhibit disruption of both TP53 alleles arguing lesions emerge from clones that lose the wild type TP53 allele within the TP53 heterozygous mutant population10,11,16. The gene discussed is TP53; the disease is cancer.